期刊文献+

影像学检测肿瘤直径和淋巴结转移在宫颈癌患者预后中的价值研究 被引量:17

Imaging-determined tumor size and lymph node status are reliable factors for predicting prognosis of advanced cervical cancer
下载PDF
导出
摘要 目的探讨影像学检测肿瘤直径和淋巴结转移在宫颈癌患者预后中的价值。方法 2008年-2012年157例在湖北省武汉市第八医院接受治疗的宫颈癌患者纳入本次研究。计算机体层摄影和/或磁共振成像检测肿瘤直径和淋巴结转移。比较肿瘤直径和淋巴结转移与临床病理因素的关系及对进展期宫颈癌预后的影响。结果单因素分析表明:8种参数具有预后显著意义,分别为阴道受累、病理学检测的淋巴结状态、肿瘤直径>6 cm、影像学检测的淋巴结状态、肾盂积水、膀胱/直肠受累、SCC-Ag含量>15 ng/ml和肿瘤分期。进一步多因素分析发现肿瘤直径和影像学检测的肿瘤直径是进展期宫颈癌患者的独立预后参数。结论肿瘤直径和影像学检测的肿瘤直径是进展期宫颈癌患者的独立预后参数。 Objective To investigate the prognostic role of tumor size and lymph node status determined by imaging in advanced cervical cancer patients. Methods The patients ( = 157) with stage IIA-IIB cervical cancer treated in our hospital between 2008 and 2012 were retrospectively enrolled. Tumor size and lymph node status were determined by CT and/or MRI. Correlations of tumor size and lymph node status with clinicopathological parameters and prognosis of advanced cervical cancer were analyzed. Results Univariate analysis showed 8 factors had remarkable prognostic significance. There were cancer stage, tumor size 〉6 cm, serum squamous cell carcinoma antigen level (SCC-Ag) 〉15 ng/ml, lower third vaginal involvement, hydronephrosis, bladder/rectum involvement, pelvic or para-aortic lymph node (LN) status detected by imaging, and pelvic LN metastasis identified by pathological examination. Furthermore, multivariate analysis revealed that tumor size and pelvic LN metastasis determined by imaging were the independent predictive variables. Conclusions Tumor size and pelvic LN metastasis measured by imaging are the independent predictive factors for the prognosis of advanced cervical cancer.
作者 马莉 杨燕
出处 《中国现代医学杂志》 CAS 北大核心 2016年第18期94-99,共6页 China Journal of Modern Medicine
关键词 宫颈癌 肿瘤直径 盆腔淋巴结 预后 uterine cervical cancer tumor size pelvic lymph node prognosis
  • 相关文献

参考文献15

  • 1胡尚英,郑荣寿,赵方辉,张思维,陈万青,乔友林.1989至2008年中国女性子宫颈癌发病和死亡趋势分析[J].中国医学科学院学报,2014,36(2):119-125. 被引量:212
  • 2陈琪,张虹.新辅助化疗在宫颈癌治疗中的作用[J].国际妇产科学杂志,2014,41(6):606-609. 被引量:14
  • 3LEE J Y, LEE C, HAHN S K, et al. Prognosis of adenosquamous carcinoma compared with adenocarcinoma in uterine cervical can- cer: a systematic review and meta-analysis of observational stud- ies[J]. International Journal of Gynecological Cancer, 2014, 24(2): 289-294. 被引量:1
  • 4HALTIA U M, Bt2TZOW R, LEMINEN A, et al. FIGO 1988 versus 2009 staging for endometriai carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype[J]. Journal of Gynecologic Oncology, 2014, 25(1): 30-35. 被引量:1
  • 5THAKER N G, KLOPP A H, JHINGRAN A, et al. Survival out- comes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system[J]. Gynecologic Ontology, 2015, 136(2): 269-273. 被引量:1
  • 6GARCES A H I, DIAS M S F, NOGUEIRA-RODRIGUES A, etal. Staging cervical cancer-current and future perspectives[J]. Austin J Obstet Gynecol, 2014, 1(4): 4-7. 被引量:1
  • 7VIZZA E, CORRADO G, ZANAGNOLO V, et al. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: A muhi-institution study[J]. Gynecologic Oncology, 2014, 133(2): 180-185. 被引量:1
  • 8GILLISON M L, CASTELLSAGUI X, CHATURVEDI A, et al. Eurogin roadmap: eomparative epidemiology of HPV infection and associated cancers of the head and neck and cervix[J]. Intenaa- tional Journal of Cancer, 2014, 134(3)i 497-507. 被引量:1
  • 9CUSCHIERI K, BREWSTER D H, GRAHAM C, et al. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer[J]. International Journal of Cancer, 2014, 135(11): 2721-2726. 被引量:1
  • 10RAUCH G M, KAUR H, CHOI H, et al. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer[J]. Radiographics, 2014, 34(4): 1082-1098. 被引量:1

二级参考文献43

  • 1钟华,彭振鹏,刘锦文,程传虎.宫颈癌MRI动态增强的病理学研究:附20例报告[J].南方医科大学学报,2009,29(7):1491-1492. 被引量:6
  • 2罗中明,黎淑贞,郭振仪,阮晓红,杨爱莲,练晓勤.44例复发性宫颈癌与淋巴结转移的相关分析[J].南方医科大学学报,2009,29(8):1712-1713. 被引量:5
  • 3吴素慧,张静,李颖,尚海霞,马纪华.子宫颈癌Ⅰb和Ⅱa期患者预后相关因素的分析[J].中华妇产科杂志,2007,42(2):131-132. 被引量:8
  • 4Lai CH, Yen TC, Ng KK. Surgical and radiologic staging of cervicalcancer [ J ]. Curr Opin Obstet Gynecol, 2010,22( 1 ) : 15-20. 被引量:1
  • 5Chou HH,Chang HP,Lai CH. F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma[J ]. Eur J Nucl Med Mol Imag, 2010,37 (4) : 728-735. 被引量:1
  • 6Grigsby PW. PET/CT imaging to guide cervical cancer therapy [J]. Future Oncol, 2009,5(7) :953-958. 被引量:1
  • 7Dolezelova H, Slampa P, Ondrova B. The impact of PET with :SF-FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma:results of pilot study [ J ]. N eoplasma,2008,55 (5):437-441. 被引量:1
  • 8Kidd EA, Siegel BA, Dehdashti F. Lymph node staging by positron e- mission tomography in cervical cancer:relationship to prognosis [J]. Clin Oncol, 2010,28(12) : 2108-2113. 被引量:1
  • 9Gouy S, Morice P, Narducci F, et al. Nodal-staging surgery for locally advanced cervical cancer in the era of PET [ J ]. Lancet Oncol, 2012, 13(5):e212-220. 被引量:1
  • 10Yildirim Y, Sehirali S, Avci ME. Integrated PET/CT for the evalua- tion of para-aortic nodal metastasis in locally advanced cervical can- cer patients with negative conventional CT findings [ J ]. Gynecol On- col,2008,108( 1 ) : 154-159. 被引量:1

共引文献237

同被引文献158

引证文献17

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部